|
“The Indian pharmaceutical industry is at the center stage in the global pharmaceutical arena and Rekvina is at the forefront in delivering the India centric advantages to the advanced and developing countries of the world. From a small domestic company at inception in middle of 80’s, Rekvina has grown formidably to be an integrated, Indian pharmaceutical company with sales in excess of twenty crore INR.
It is with the unwavering 'dedication' and the 'Will to Win ' of Team Rekvina across India that we have traversed this journey so far.
We are committed to provide quality medication at affordable prices to the patients with a view to help bring down the healthcare costs. We are confident that our efforts would see the Company grow from strength to strength in the global space in the years to come. Whilst we continue to enhance the momentum of our products, we are also accelerating our drug discovery program through collaborations and alliances.
As we move ahead we are determined to capitalize on the new opportunities based on our strong fundamentals of innovation, entrepreneurship and aggressive marketing. We remain committed to actively pursue our strategy of growth through organic and inorganic means.
Today, we are well prepared to be amongst the top 100 pharmaceutical companies of India and attain a size of 100 crore INR by 2020. As we step into the next phase, we are driven by our ambition, willing to invest in the growth of our people and business, marching towards the new horizon of global leadership."
Mr. Mukesh Shah
Chairman & Managing Director | 
To emerge as a global Pharma player. To enter the advanced markets of the world with a sustained presence over the long-term.